PATENT CLAIM ANALYSIS

Application Number: 16003173
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "456000"]

Abstract:
The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g., a poloxamer. The pharmaceutical competitions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.

Claim (Index 127):
The pharmaceutical composition of  claim 123 , wherein said weight ratio of said anti-adherent agent to said oxidized phospholipid is from about 1:4 to about 1:1.

Metadata:
- Claim Count in Document: 79.0
- Percentile: 94.0
- Lexical Diversity: 1.7551
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13792633', '13127717', '13085542', '10567543', '12985365']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.684935459724357
- 35 USC 102 Novelty (BERT): 0.6027628237171166
- Combined Prediction Score: 0.6767181961236329
- Mean Citation Score: 263.15988
- Max Citation Score: 560.7445
- Similarity Product: 455.18237297815085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test